Microsatellite Instability-high Tumors

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-05-19
Clinical Trial Update: Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D) [Phase 2]
Phase 2 study of pembrolizumab (MK-3475) in microsatellite instability-high tumors (Cohort D) has completed with results posted.